Customized analysis.
We’d love to hear from you.
Providing access and choice to patients.
SubjectWell was founded on the idea that we could solve patient-recruitment problems by applying techniques that have been proven in other industries. And, in doing so, we could connect millions of patients with the medical care and guidance they wouldn’t have access to otherwise.
Today, our goal is to help people live longer, healthier, better lives. Through global communication, education-based outreach, and our clinical trials marketplace, we’re working to make more and more people aware of clinical trial opportunities – and the lasting benefits they provide.
Providing access and choice to patients.
SubjectWell was founded on the idea that we could solve patient-recruitment problems by applying techniques that have been proven in other industries. And, in doing so, we could connect millions of patients with the medical care and guidance they wouldn’t have access to otherwise.
Today, our goal is to help people live longer, healthier, better lives. Through global communication, education-based outreach, and our clinical trials marketplace, we’re working to make more and more people aware of clinical trial opportunities – and the lasting benefits they provide.
Providing access and choice to patients.
CT-Line was born out of the idea that every person should have access to the latest and greatest that healthcare has to offer. We are here to change that.
CT-Line was born out of the idea that every person should have access to the latest and greatest that healthcare has to offer. We are here to change that.
CT-Line was born out of the idea that every person should have access to the latest and greatest that healthcare has to offer. We are here to change that.
Located in Austin and Cape Town.
Headquarters in Austin, Texas
Office in Cape Town, South Africa
Try our risk-free assessment.
With your protocol information, we’ll use real-world data to compile a complete and accurate assessment of how many qualified patients we can reach.